CPIX
Cumberland Pharmaceuticals Inc.

2,599
Mkt Cap
$57.73M
Volume
124,300.00
52W High
$7.25
52W Low
$1.85
PE Ratio
-16.56
CPIX Fundamentals
Price
$3.80
Prev Close
$3.86
Open
$3.99
50D MA
$3.54
Beta
0.60
Avg. Volume
211,814.45
EPS (Annual)
-$0.4609
P/B
2.21
Rev/Employee
$416,131.26
Loading...
Loading...
News
all
press releases
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average - What's Next...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Zacks·19d ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Top Research Reports for NVIDIA, Netflix & Merck
New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.
Zacks·2mo ago
News Placeholder
Zacks Initiates Coverage of CPIX With Outperform Recommendation
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates Cumberland as "Outperform." Explore how CPIX's scalable commercial model, long-duration Talicia revenues and pipeline upside create an attractive risk-reward setup for investors.
Zacks·2mo ago
News Placeholder
CALDOLOR (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT
CALDOLOR (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT CALDOLOR (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH...
PR Newswire·2mo ago
News Placeholder
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH PR Newswire NASHVILLE, Tenn., Nov. 4, 2025 NASHVILLE, Tenn., Nov...
PR Newswire·3mo ago
News Placeholder
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn., Oct...
PR Newswire·3mo ago
News Placeholder
CUMBERLAND PHARMACEUTICALS' VIBATIV ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
CUMBERLAND PHARMACEUTICALS' VIBATIV ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. CUMBERLAND PHARMACEUTICALS' VIBATIV ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC...
PR Newswire·4mo ago
<
1
2
...
>

Latest CPIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.